Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
KPTI
KPTI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KPTI News
Wall Street Analysts Adjust Ratings on Key Stocks
12h ago
Benzinga
FDA's Accelerated Approval Framework Drives Cancer Treatment Advances
Feb 17 2026
Newsfilter
Karyopharm Therapeutics Q4 2025 Earnings Call Highlights
Feb 13 2026
seekingalpha
Karyopharm (KPTI) Q4 2025 Earnings Call Transcript
Feb 12 2026
NASDAQ.COM
Karyopharm Q4 Earnings Beat Expectations, 2026 Outlook Positive
Feb 12 2026
seekingalpha
Karyopharm Reports 2025 Financial Results and 2026 Outlook
Feb 12 2026
PRnewswire
Karyopharm Reports 2025 Financials and 2026 Outlook
Feb 12 2026
Newsfilter
Karyopharm Therapeutics to Announce Q4 Earnings on February 12
Feb 11 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Feb 05 2026
Benzinga
Karyopharm to Report Q4 and Full Year 2025 Results on February 12, 2026
Feb 05 2026
PRnewswire
Karyopharm Grants Restricted Stock Units to New Employees
Feb 02 2026
PRnewswire
Karyopharm Projects $145 Million Total Revenue for 2025 Amid Upcoming Clinical Trials
Jan 12 2026
PRnewswire
Karyopharm Grants 1,533 RSUs to New Employees as Inducement
Jan 02 2026
PRnewswire
Karyopharm Grants 1,533 RSUs to New Employees as Inducement
Jan 02 2026
Newsfilter
Karyopharm to Host Virtual Fireside Chat on December 10, 2025
Dec 08 2025
PRnewswire
Karyopharm to Participate in Baird's Biotech Discovery Series on December 10
Dec 08 2025
Newsfilter
Show More News
